Endostar protein: all 88 studies that test it

Page 1 of 1. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain MetastasesNot yet recruitingNCT07841106Phase 2
• SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLCNot yet recruitingNCT07818304Phase 2
• Platinum-Free Regimen in Nasopharyngeal CarcinomaNot yet recruitingNCT07794488Phase 2
• Local Injection and Systemic Therapy in the Treatment of NSCLC.Not yet recruitingNCT06618391Phase 2
• Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.RecruitingNCT06617936Phase 2
• GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPCNot yet recruitingNCT06611826Phase 2
• Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal TumorsRecruitingNCT06301828Phase 2
• Recombinant Human Endostatin Combined With Envafolimab and Synchronal RadiochemotherapyNot yet recruitingNCT06279754Phase 2
• Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous MelanomaRecruitingNCT05907512Phase 2
• Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLCRecruitingNCT05203276Phase 2
• Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal CarcinomaRecruitingNCT05177237Phase 2
• Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent GliomasRecruitingNCT04267978Phase 2
• Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical CancerRecruitingNCT03622827Phase 2
• Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in OsteosarcomaCompletedNCT06562673Phase 1/2
• Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT06055816Phase 2
• First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm TrialStatus unknownNCT05574998Phase 2
• Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal CancerStatus unknownNCT05551247Phase 2
• Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung CancerStatus unknownNCT05529355Phase 2
• Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic CancerStatus unknownNCT05298020Phase 2
• PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based ChemotherapyStatus unknownNCT04942301Phase 1
• Endostar Combined With AI Regimen Compared With AI in Adjuvant TreatmentStatus unknownNCT04699214Phase 2
• Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLCStatus unknownNCT04613284Phase 4
• Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal MetastasisStatus unknownNCT04356118Phase 4
• SBRT With S1 Combined With Endostar in the Treatment of Lung CancerStatus unknownNCT04274270Not applicable
• Study of Endostar Combined With TP Regimen for Esophageal CancerStatus unknownNCT04164797Phase 4
• CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical CancerStatus unknownNCT04121975Phase 2
• Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLCStatus unknownNCT04094909Phase 2
• Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLCStatus unknownNCT04063449Not applicable
• Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal CarcinomaStatus unknownNCT03932266Phase 2
• Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast CancerStatus unknownNCT03907098Phase 2
• Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasCompletedNCT03797625Phase 2
• Clinical Study of Endostatin in Improving Radiation Pneumonia and FibrosisCompletedNCT03796364Phase 2
• Rh-Endostatin (Endostar®) Continuous Intravenous InfusionStatus unknownNCT03706703Phase 2
• Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal CancerStatus unknownNCT03649945Phase 2
• Endostar Combine With Radiotherapy in Brain Metastasis of NSCLCStatus unknownNCT03614065Phase 2
• Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)Status unknownNCT03208335Phase 2
• Endostar First-line Treatment of Advanced NSCLCStatus unknownNCT03123445Phase 2
• Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue SarcomaCompletedNCT03121833Phase 2
• Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic MelanomaStatus unknownNCT03095079Phase 2
• Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical CarcinomaCompletedNCT03086681Phase 2
• Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02907710Phase 3
• A Trial of Endostar in Patients With Carcinoma of the Head and NeckStatus unknownNCT02902432Phase 2
• The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC PatientsStatus unknownNCT02865304Phase 3
• Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung AdenocarcinomaStatus unknownNCT02804646Phase 4
• Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasStatus unknownNCT02665702Phase 2
• Study of Endostar Subcutaneous Injection in NSCLCStatus unknownNCT02652234Phase 1
• Anti-angiogenetic Therapy With Radiotherapy for Pediatric NeuroblastomaStatus unknownNCT02615106Phase 2
• A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPCStatus unknownNCT02590133Phase 2
• Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical StudyStatus unknownNCT02520219Phase 2
• Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous CarcinomaStatus unknownNCT02513342Phase 4
• A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal CarcinomaCompletedNCT02444949Phase 2
• Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR MutationsStatus unknownNCT02375022Phase 2
• Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal CancerCompletedNCT02350517Phase 2
• Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.Status unknownNCT02350361Phase 2/3
• Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal CarcinomaCompletedNCT02237924Phase 2
• Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric CancerStatus unknownNCT02008422Phase 3
• Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLCStatus unknownNCT02005120Phase 2
• Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠBStatus unknownNCT02001168Phase 3
• Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01915134Phase 3
• A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast CancerStatus unknownNCT01907529Phase 2/3
• Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal CancerStatus unknownNCT01832948Phase 2
• Endostar + GT in Pulmonary Metastases of Soft Tissue SarcomaStatus unknownNCT01812018Phase 2
• Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLCCompletedNCT01733589Phase 1/2
• Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)CompletedNCT01687439Phase 2
• The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With EndostarStatus unknownNCT01564329Phase 2
• Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT01549093Phase 2
• A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer PatientsCompletedNCT01531790Phase 1
• Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain MetastasesStatus unknownNCT01410370Phase 2
• Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer PatientsStatus unknownNCT01368419Phase 2
• Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or AscitesCompletedNCT01327235Phase 2
• Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal CancerStatus unknownNCT01310478Phase 1
• Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)Status unknownNCT01158144Phase 2
• Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)CompletedNCT01124253Phase 3
• A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01028729Phase 4
• A Study of Endostar Combined With Chemotherapy for Treatment of OsteosarcomaStatus unknownNCT01002092Phase 2
• Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell LymphomaStatus unknownNCT00974324Phase 2
• Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)CompletedNCT00912392Phase 2
• Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal CancerStatus unknownNCT00853684Phase 2
• Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma PatientsCompletedNCT00849264Phase 2
• Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced MelanomaStatus unknownNCT00813449Phase 2
• Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)Status unknownNCT00813332Phase 4
• FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal CancerStatus unknownNCT00813137Phase 2
• Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00708812Phase 2
• Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT00657423Phase 3
• Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung CancerStatus unknownNCT00576914Phase 3
• rhEndostatin Protein Involving Pediatric Patients With CancerTerminatedNCT00165373Phase 1
• Endostatin in Treating Patients With Advanced Refractory Solid TumorsCompletedNCT00004872Phase 1
• Endostatin in Treating Patients With Advanced Solid TumorsCompletedNCT00004229Phase 1

← Endostar protein overview